Clover Health Investments (CLOV) Change in Accured Expenses (2020 - 2026)

Clover Health Investments' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 173.77% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 161.52% YoY) and the FY2025 annual result came in at $1.6 million, up 162.86% from the prior year.
• Change in Accured Expenses was $3.0 million for Q1 2026 at Clover Health Investments, down from $3.3 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $15.0 million in Q1 2023 and bottomed at -$17.0 million in Q4 2024.
• A 5-year average of $844705.9 and a median of $3.0 million in 2026 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 2313.42% in 2023, while the deepest fall reached 3418.5% in 2023.
• Clover Health Investments' Change in Accured Expenses stood at $3.1 million in 2022, then soared by 38.84% to $4.4 million in 2023, then plunged by 489.4% to -$17.0 million in 2024, then soared by 119.24% to $3.3 million in 2025, then decreased by 9.59% to $3.0 million in 2026.
• Business Quant data shows CLOV's Change in Accured Expenses at $3.0 million in Q1 2026, $3.3 million in Q4 2025, and -$1.0 million in Q3 2025.